PharmaCyte Biotech Inc (PMCB)

[concordia]

The ONLY focus this company should have right now is proving CIAB works. If the P2B trial is successful it will open up all of the options and resources they will need for other applications if it is not successful then it will be over for this company and all of the CIAB rights will go back to Austrianova or whoever gets them in bankruptcy court. I do agree that you better get it right the first time because a company this small with no cash only has one shot but allowing the PPS to dip this low has also created a cash problem. Yes i do blame Kenny Esq for this as he should have raised the cash he needed when he could of. Many companies raise the funds they need well before clinical trials. Now he is playing a very weak hand with anyone willing to fund them and that always is bad news for existing shareholders.